Donald L Hertzog

Title: The Innovative Contributions of Donald L. Hertzog

Introduction

Donald L. Hertzog is a notable inventor based in Durham, NC (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 2 patents, he has made strides in developing compounds that address critical health issues, particularly in pain management.

Latest Patents

Hertzog's latest patents include innovative compounds such as MAGL inhibitors, which consist of piperazine carbamates and pharmaceutical compositions. These compounds are designed to modulate MAGL and are particularly useful in the treatment of pain. Another significant patent involves pyrimidinones as melanin concentrating hormone receptor 1, which details a compound of formula (Ia) that includes a pharmaceutically acceptable salt or solvate. This patent also covers formulations, processes of preparing, and methods of administering these compounds to mammals.

Career Highlights

Throughout his career, Donald L. Hertzog has worked with prominent companies in the pharmaceutical industry, including Abide Therapeutics, Inc. and SmithKline Beecham Corporation. His work in these organizations has contributed to the advancement of therapeutic solutions in various medical fields.

Collaborations

Hertzog has collaborated with esteemed colleagues such as Cheryl A. Grice and Daniel J. Buzard, further enhancing the impact of his research and innovations.

Conclusion

Donald L. Hertzog's contributions to pharmaceutical inventions demonstrate his commitment to improving health outcomes through innovative solutions. His work continues to influence the field and inspire future advancements in medicine.